Hola a tod@s , noticia buena..
10. Zeltia: overseas funds build stakes on back of Yondelis potential - reports Main body : Zeltia, the listed Spanish pharmaceutical company, is seeing unknown overseas investment funds build stakes in the company, reported La Gaceta. The report, citing market sources, said a number of funds had been building stakes over the last month.
It is widely believed in the market, the report said, that Zeltia will soon seek approval in the United States and in the European Union for its anti-cancer drug Yondelis to be used in patients with ovarian cancer, the report said. If the drug is approved, it could double Zeltia's value, the article said. Source : La Gaceta de los Negocios Size : > 500m(USD) Value : 1,865 m USD(Zeltia market cap) Stake Value : N/A Grade : Rumored Alert : Biotech Pharma Alert Intelligence ID : 632503